Extracellular Vesicles Derived from Breast Cancer Cells: Emerging Biomarkers of Tumor Progression and Metastasis
Biomolecules · 2025
DOI: 10.3390/biom15081195 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Sona Bernatova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Extracellular Vesicles, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comenius University Bratislava, Comenius University.
Abstract (Originalsprache)
Breast cancer (BC) remains one of the most prevalent and life-threatening malignancies worldwide, marked by significant heterogeneity and complex mechanisms of progression. Despite major advances in understanding its molecular and cellular basis, the processes driving tumor progression and metastasis continue to challenge effective treatment. Among the emerging research areas, extracellular vesicles (EVs) have gained considerable attention for their key role in intercellular communication and their contribution to cancer biology. In BC, tumor cell-derived EVs are implicated in multiple processes that promote disease progression, including tumor growth, remodeling of the tumor microenvironment, and facilitation of metastasis. By transferring oncogenic signals to recipient cells, EVs critically shape the metastatic niche and support the spread of cancer cells to distant organs. Recent studies highlight the diverse functions of BC-derived EVs in modulating immune responses, inducing angiogenesis, and enhancing cancer cell invasiveness. This review explores the role of BC-derived EVs in tumor progression and metastasis. We discuss their molecular composition, mechanisms of action, and impact on the tumor microenvironment, aiming to provide insights into their role in BC pathophysiology and discuss potential clinical applications. A deeper understanding of the complex interplay between EVs and cancer progression may pave the way for innovative strategies to combat BC and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia.
- 2nd Department of Oncology, Faculty of Medicine, Comenius University, Klenova 1, 833 10 Bratislava, Slovakia.
ORCID-Profile: Sona Bernatova, Andreas Nicodemou, Michaela Cehakova, Lubos Danisovic, Martin Bohac
Förderung
- Comenius University Bratislava
- Comenius University
Zitieren
APA
Bernatova, S., Nicodemou, A., Cehakova, M., Danisovic, L., & Bohac, M. (2025). Extracellular Vesicles Derived from Breast Cancer Cells: Emerging Biomarkers of Tumor Progression and Metastasis. Biomolecules. https://doi.org/10.3390/biom15081195
Vancouver
Bernatova S, Nicodemou A, Cehakova M, Danisovic L, Bohac M. Extracellular Vesicles Derived from Breast Cancer Cells: Emerging Biomarkers of Tumor Progression and Metastasis. Biomolecules. 2025. doi:10.3390/biom15081195
BibTeX
@article{Bernatova2025,
author = {Bernatova, Sona and Nicodemou, Andreas and Cehakova, Michaela and Danisovic, Lubos and Bohac, Martin},
title = {Extracellular Vesicles Derived from Breast Cancer Cells: Emerging Biomarkers of Tumor Progression and Metastasis},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15081195}
}
EUVIMED